PM
RAPT

Ponoi Management’s RAPT Therapeutics RAPT Stock Holding History

Ponoi Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$38.5M Hold
199,927
– – 52.54% 1
2022
Q2 		$29.2M Hold
199,927
– – 46.09% 1
2022
Q1 		$35.2M Hold
199,927
– – 45.65% 1
2021
Q4 		$58.7M Hold
199,927
– – 54.16% 1
2021
Q3 		$49.7M Hold
199,927
– – 44.09% 1
2021
Q2 		$50.8M Hold
199,927
– – 28.25% 2
2021
Q1 		$35.5M Hold
199,927
– – 20.88% 3
2020
Q4 		$31.6M Buy
+199,927
New +$43.5M 18.07% 3

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Ponoi Management's RAPT Position: Q3 2022 in Review

Ponoi Management held its RAPT Therapeutics (RAPT) position steady in Q3 2022 at 199,927 shares worth $38.5M. The position accounts for 52.54% of the portfolio, ranked #1.

Ponoi Management first reported a position in RAPT in Q4 2020 and has held it in 8 quarters since. The position peaked at $58.7M in Q4 2021. 98 funds tracked by Wall St. Rank hold RAPT as of Q3 2022.

  • Ponoi Management held 199,927 shares of RAPT Therapeutics worth $38.5M as of Q3 2022.
  • Ponoi Management left its RAPT Therapeutics share count unchanged in Q3 2022.
  • RAPT Therapeutics made up 52.54% of Ponoi Management's portfolio in Q3 2022, its #1 holding.
  • Ponoi Management first reported a position in RAPT Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • Ponoi Management's RAPT Therapeutics position peaked at $58.7M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q3 2022.

Based on Ponoi Management's 13F filing for Q3 2022, filed 14 Nov 2022.